Baseline characteristics of trial participants
| Intervention group n = 47 | Control group n = 44 | |
|---|---|---|
| Age (years) | 64 ± 10 | 65 ± 11 |
| Women (n) | 25 | 26 |
| Ethnicity: Caucasian (%) | 100 | 100 |
| Type 1 diabetes (n) | 3 | 3 |
| Duration of diabetes (years) | 18 ± 11 | 14 ± 10 |
| BMI (kg/m2) | 28.4 ± 4.5 | 28.6 ± 4.3 |
| HbA1c (%) | 8.5 ± 1.6 | 8.4 ± 1.6 |
| RR systolic/diastolic (mmHg) | 147/80 | 144/80 |
| Insulin therapy (n) | 38 | 29 |
| Retinopathy (n) | 28 | 25 |
| Nephropathy (n) | 21 | 19 |
| Peripheral vascular disease (n) | 22 | 20 |
| Therapeutic shoes (n) | 28 | 26 |
| Amputation: minor* (n) | 12 | 13 |
| Amputation: major† (n) | 2 | 3 |